GIS
31
3
CA
38
6
FDX
43
3
GT
62
6
SO
53
-4
BWA
48
2
SE
61
-4
STZ
54
-3
INTU
56
-4
CL
58
2
LEG
36
4
FITB
63
3
WM
79
3
MA
64
7
F
58
11
XRX
44
3
CRM
67
2
NOC
43
11
NDAQ
62
2
A
43
2
GIS
31
3
CA
38
6
FDX
43
3
GT
62
6
SO
53
-4
BWA
48
2
SE
61
-4
STZ
54
-3
INTU
56
-4
CL
58
2
LEG
36
4
FITB
63
3
WM
79
3
MA
64
7
F
58
11
XRX
44
3
CRM
67
2
NOC
43
11
NDAQ
62
2
A
43
2
Financhill
Back

Novartis AG Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62

NVS
Novartis AG

Last Price:
104.27
Seasonality Move:
1.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Novartis AG Price Quote

$104.27
-0.01 (0.4%)
(Updated: November 23, 2024 at 5:47 AM ET)

Novartis AG Key Stats

Buy
62
Novartis AG (NVS) is a Buy
Day range:
$104.18 - $105.19
52-week range:
$92.35 - $120.92
Dividend yield:
3.62%
P/E ratio:
14.69
P/S ratio:
4.28
P/B ratio:
4.81%
Volume:
1.3M
Avg. volume:
1.2M
1-year change:
7.41%
Market cap:
$208.5B
Revenue:
$46.7B
EPS:
$8.53

How Much Does Novartis AG Make?

  • How Much Are Novartis AG's Sales Annually?
    NVS Revenues are $46.7B
  • How Much Profit Does Novartis AG's Make A Year?
    NVS net income is $14.9B

Is Novartis AG Growing As A Company?

  • What Is Novartis AG's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.09%
  • What Is Novartis AG's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.85%

Novartis AG Stock Price Performance

  • Did Novartis AG Stock Go Up Last Month?
    Novartis AG share price went down by -8.78% last month
  • Did NVS's Share Price Rise Over The Last Year?
    NVS share price rose by 7.41% over the past 1 year

What Is Novartis AG 52-Week High & Low?

  • What Is Novartis AG’s 52-Week High Share Price?
    Novartis AG has traded as high as $120.92 over the past 52 weeks
  • What Is Novartis AG’s 52-Week Low Share Price?
    Novartis AG has traded as low as $92.35 over the past 52 weeks

Novartis AG Price To Free Cash Flow

Is It Risky To Buy Novartis AG?

  • How Much Debt Does Novartis AG Have?
    Total long term debt quarterly is $30.3B
  • How Much Cash Does Novartis AG Have?
    Cash and short term investments quarterly total is $14B
  • What Is Novartis AG’s Book Value Per Share?
    Book value per share is 21.67

Is Novartis AG Cash Flow Positive?

  • What Is NVS Cash Flow From Operations?
    Cash flow from operations (TTM) is $16B
  • What Is Novartis AG’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$9.4B
  • What Is Novartis AG’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.2B

Novartis AG Return On Invested Capital

  • Is Management Doing A Good Job?
    NVS return on invested capital is 25.8%
  • What Is Novartis AG Return On Assets?
    ROA measures how assets are converting to revenues and is 17.33%
  • What Is NVS Return On Equity?
    ROE is a measure of profitability and is 41.89%

Novartis AG Earnings Date & Stock Price

  • What Is Novartis AG's Stock Price Today?
    A single share of NVS can be purchased today for 104.28
  • What Is Novartis AG’s Stock Symbol?
    Novartis AG trades on the nyse under the ticker symbol: NVS
  • When Is Novartis AG’s Next Earnings Date?
    The next quarterly earnings date for Novartis AG is scheduled on January 31, 2025
  • When Is NVS's next ex-dividend date?
    Novartis AG's next ex-dividend date is March 7, 2024
  • How To Buy Novartis AG Stock?
    You can buy Novartis AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Novartis AG Competitors

  • Who Are Novartis AG's Competitors?
    Below is a list of companies who compete with Novartis AG or are related in some way:
    • AstraZeneca PLC (AZN)
    • Monte Rosa Therapeutics Inc (GLUE)
    • Eli Lilly and Co (LLY)
    • Novo Nordisk AS (NVO)
    • Pfizer Inc (PFE)

Novartis AG Dividend Yield

Novartis AG Analyst Estimates

YoY Growth Past Surprise
EPS: 84.71% 6.57%
Revenue: 8.93% 1.24%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 11
Sell Recommendations: 0
Price Target: 116.16
Upside from Last Price: 11.39%

Major Shareholders

  • How many NVS shares are owned by institutional investors?
    174.2M NVS shares are owned by institutional investors
  • How many NVS shares are owned by insiders?
    0 NVS shares are owned by insiders